JD Schaub Email

EVP, COO . RVL Pharmaceuticals

Current Roles

Employees:
14
Revenue:
$165.9M
About
RVL Pharmaceuticals, Inc. is a new operating subsidiary of Osmotica Pharmaceuticals plc (Nasdaq: OSMT), and was created for the purpose of bringing Upneeq® (oxymetazoline hydrochloride ophthalmic solution), 0.1% to market. RVL Pharmaceuticals, Inc. is dedicated to developing unique partnerships with customers, as well as making Upneeq® available exclusively through our fully-owned and integrated pharmacy. Osmotica Pharmaceuticals plc is a fully integrated biopharmaceutical company focused on the development and commercialization of specialty products that target markets with underserved patient populations.
RVL Pharmaceuticals Address
400 Crossing Blvd
Bridgewater, NJ
United States
RVL Pharmaceuticals Email

Past Companies

RVL Pharmaceuticals, Inc.EVP, COO
Osmotica/Vertical/TrigenEVP, Commercial Operations/COO
Avista CapitalHealthcare Industry Consultant

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.